Valerie Anne Schmidt, OTR Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 780 Heather Cir, Lake Geneva, WI 53147 Phone: 815-482-4504 Fax: 262-248-2309 |
Laura-lee Schwefel, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 921 Park Dr, Suite A, Lake Geneva, WI 53147 Phone: 262-248-6855 Fax: 262-248-6840 |
Kali R Carlson, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: N2680 S Como Rd, Lake Geneva, WI 53147 Phone: 262-215-4326 |
Susan Lynn Bosman, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 211 S Curtis St, Lake Geneva, WI 53147 Phone: 262-248-3145 |
News Archive
Cellectis, the genome engineering specialist, has announced successfully programming cells from the immune system (T cells) to kill cancer cells. This technological breakthrough was revealed for the first time ever on Saturday, October 27th at the congress of the ESGCT (European Society of Gene & Cell Therapy) in Versailles, outside Paris.
After gobbling the fourth Oreo in a row while bathed in refrigerator light, have you ever thought, "That wasn't enough," and then proceeded to search for something more? Researchers at BYU have shed new light on why you, your friends, neighbors and most everyone you know tend to snack at night: some areas of the brain don't get the same "food high" in the evening.
For three years, Andrew Harder wondered if he had prostate cancer. In 2009, he had routine blood work that revealed an elevated prostate-specific antigen (PSA) level.
Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.
A comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity-modulated radiation therapy (IMRT) for prostate cancer among urologists with an ownership interest in the treatment was due to self-referral, according to new research, "Urologists' Use of Intensity-Modulated Radiation Therapy for Prostate Cancer," released today in The New England Journal of Medicine (NEJM) for its October 24, 2013 issue.
› Verified 8 days ago